Renal Flashcards
For any pt with renal failure need to:
- assess degree of renal impairment
- make changes
- change to safer drug
- avoid nephrotoxics
Routine tests are:
- Plasma
* Urine
Plasma routine tests
- Creatinine
- Urea
- eGFR
Urine routine tests
- ACR/Albumin:creatinine ratio
- Osmolality
- specific gravity
- proteinuria/microalbuminuria
- haematuria
- mid stream urine
Creatinine
GFR = Cr Cl
• freely filtered by kidney
• product of protein metabolism
• 24hr urine collection
Limitations in urine collection/creatinine
- accuracy of urine collection
* time delay
Cockcroft & Gault equation
CrCl = [140-age]*IBW / Plasma Cr [umol/l]
* F
(F = 1.23 males, 1.04 females)
Limitations with Cockcroft & Gault equation
- assume average population data
- unsuitable for children and pregnancy
- renal fn must be stable
normal CrCl
120ml/min
normal CR
55 - 125umol/l
Metabolism in kidney impairment
- less vitD activated
- less insulit met
- less elimination API metabolites
eGFR 4 variables
age, sex, serum Cr, ethnic origin
Stages of eGFR
1 >90 Normal 2 60-89 Mild impairment 3a 45-59 3b 30-44 Mod 4 15-29 Severe 5 <15 End stage
eGFR units
ml/min/1.73m^2
Stage 1 G1
> 90 Normal
Stage 2 G2
60-89 Mild impairement
Stage 3A G3a
45-59
Stage 3B G3b
30-44 Mod
Stage 4 G4
15-29 Severe
Severe 5 G5
<15 End Stage
Urea - what is it
Breakdown product of protein metabolism
Uraemia
Urea in blood. >15mmol/l
High urea levels also in:
- dehydration
- excess protein intake
- haemorrhage
- severe infection
- muscle injury
Proteinuria
- ACR Albumin:Creatinin Ratio
- predictor of renal disease development
- predicts risk of AE
ACR
Albumin:Creatinine Ratio
uraemia in absorption
- vomiting diarrhoea, GI, oedema
- reduce Ca2+ absorption
- phosphate binders
uraemia in distribution
- reduce protein binding in drugs eg phenytoin
* reduce tissue binding in drugs eg digoxin
kidney impairment in metabolism
- VitD - less activation
- insulin - less met
- API metabolites - less elimination
dose adjustments - kidney impairment
- reduce dose
* increase dose interval
Loading dose adjustment - kidney impairment
none
Ideal drug in renal impairment
- wide therapeutic index
- liver eliminate
- not nephrotoxic
- not affected by changes in fluid balance, tissue or protein binding
kidney fn
- regulatory
- excretory
- endocrine
pre renal failure
less renal perfusion
intrinsic renal failure
damage to renal tissue
post renal failure
obstruction to urinary flow eg • Stones • structural eg tumour • nephrotoxicity • outside urinary tract eg ovarian tumour
Eg of urinary flow obstruction
- Stones
- Structural eg tumour
- nephrotoxicity
- outside urinary tract eg ovarian tumour
AKI reversible?
Yes
AKi secondary to?
decreased circulation (pre-renal failure)
AKI is
regulatory & excretory failure
AKI defined in terms of Cr
increased Cr ≥ 26 µmol/l
AKI defined in terms of urine output
decreased urine output to <0.5ml/kg/hr for >6hrs
Risk factors AKI
- Past AKI
- pre-existing CRF
- age >65yrs
- CCF
- PVD
- DM
- hepatic disease
AKI trigger factors
- sepsis/infection
- hypovolaemia (dehydration, bleeding)
- Hypotension
- drugs eg NSAIDs, ACEIs, ARBs, Diuretics
Drugs that could trigger AKI
- NSAIDS
- ACEIs
- ARBs
- Diuretics
AKI prevention
- avoid nephrotoxic drugs
- Monitor renal function for drugs known to cause renal impairment
- Review meds known to exacerbate AKI
Meds that exacerbate AKI
ACEI,
CRB,
diuretics
Signs of AKI
- Volume depletion
* Volume overload
Volume depletion signs of AKI
- Thirst
- Fluid loss ++
- Oliguria
- Dry mucosae
- low skin elasticity
- tachycardia
- hypotension
- low JVP
Volume overload (if left untreated)
- increased orthopnoea/fluid in lungs
- increased PND/ nocturnal dyspnoea
- SOA
- Oedema
- pulmonary oedema
- pulmonary crackles
PND
paroxysmal noctural dyspnoea
Treatment of AKI - Underlying causes
- Restoration of renal perfusion - IV fluids, blood
- Dialysis
- Review drug therapy - stop/withhold nephrotoxic drugs
AKI restoration of renal perfusion
- IV fluids eg NaCl 0.9%
* Blood
AKI Loop diuretics - what,
Furosemide IV
• doses 1-2g IV over 24hrs
AKI Loop diuretics - why
- produces diuresis, which decreases tubular cell metabolic demands & renal blood flow.
- increases renal prostaglandins/PG
- caution for dehydration
AKI Furosemide max rate IV
4mg/min (higher causes ototoxicity)
Ototoxicity
damage hear, hearing loss, balance disorders, ringing/tinnitus
Dopamine in AKI why
- renal vasodilation mediated through D1 receptors.
* increases renal perfusion
Dopamine in AKI dose
- low dose (2mcg/min)
* high dose >5mcg/kg/min can cause vasoconstriction
Antibiotics in AKI
if cause is infection
CKD
Chronic Kidney Disease
CKD what is it
- Regulatory, excretory & endocrine failure
- secondary to renal tissue damage
- subtle & slow onset
- irreversible by the time pt presents with symptoms
CKI reversible?
irreversible by the time pt presents with symptoms
ESRF
End Stage Renal Failure
ESRF treatment
- renal replacement therapy needed eg.
* dialysis or transplantation
Acute on Chronic Renal Failure
• sudden fast decline due to underlying cause eg dehydration. infection, drugs
Clinical manifestations of CKD
- Urinary symptoms
- Proteinuria
- Fluid retention
- Uraemia
- Anaemia
- electrolyte disturbance
- HYP
- muscle dysfn
Urinary symptoms CKD
- v. early stages only polyuria
- polyuria
- medullary damage
- osmotic effect of urea (>40mmol/l)
- loss of ability to [urine]
- nocturia
Proteinuria CKD
- degree of proteinuria in all CKD
- proteinuria >2g in 24hr leads to glomerular disease
- > 5g in 24hr leads to severe disease = Nephrotic syndrome
Nephronic syndrome
> 5g in 24hr proteinuria
proteinuria
protein in urine
Glomerular disease
> 2g in 24hr
Fluid retention CKD
- CKD progress = GFR lowers
- kidneys can’t excrete Na+ & water leads to peripheral and pulmonary oedema & ascites
- 80% of CKD pt have volume dependent HT
Uraemia CKD
- measurement of toxin level in blood
- often used to decide when to start dialysis
- Symptoms eg anorexia, N&V
Uraemia symptoms
anorexia N&V constipation foul taste skin discoloration • pruritis
Anaemia CKD
- failure of kidney to produce erythropoetin hormone
- regulates RBC proliferation in bone marrow
- symptoms eg fatigue
Anaemia symptoms
- fatigue and lethargy
- breathlessness
- angina
Electrolyte disturbance CKD
- hyperkalaemia
* Acidosis
Hyperkalaemia
- kidneys unable to remove K+
* >7mmol/l = medical emergency & risk of cardiac arrest
Acidosis
- kidneys cant remove H+
* reduce plasma bicarbonate
Hypertension
- majority CKD pt have it
- mainly due to circulatory volume expansion due to Na+ retention
- increases rate of decline of renal fn
Muscle dysfunction
- cramps & restless legs
- especially at night
- general nutritional deficiencies & electrolyte disturbances
Renal bone disease/ osteodystrophy from what?
- Cholecalciferol (inactive precursor of vitD) absorbed from GIT & produced in dkin from sunlight
- To produce active vitD calcitriol, cholecalciferol needs hydroxylation in 25 position in liver and 1𝒶 position in kidney.
- leads to VitD deficiency
- defective bone mineralisation
- osteomalacia/ bone softening
osteomalacia
bone softening
How VitD deficiency?
- cholecalciferol needs hydroxylation in 25 position in liver. 1𝒶 position in kidney.
- ESFR cannot do this.
- active vitD decrease
- vitD deficiency
- defective bone mineralisation
- osteomalacia/ bone softening
vitD leads to?
Why low Ca2+?
- vitD cannot absorb Ca2+ from gut
- less vitD = less Ca2+
- low bone mineralisation/ osteomalacia
hypocalcaemia leads to?
- release of PTH/parathyroid hormone
- 2º/leads to hyperparathyroidism/hyperplasia of parathyroid gland
- disrupt bone structure
- bone hardening/osteosclerosis
hypocalcaemia can be exacerbated by
- hyperphosphataemia as kidney cannot excrete phosphate
* Phosphate ions can sequester Ca2+ into calcium phosphate in bones.
Why hyperphosphataemia?
- kidney cant excrete phosphate
* leads to hypocalcaemia as Phosphate ions sequester Ca2+ as calcium phosphate in bones.
Hyperphosphataemia can lead to?
- lead to pruritis
- leads to hypocalcaemia
- disturb bone architecture
- osteosclerosis/ bone hardening
- bone pain
PTH
parathyroid hormone
PTH in osteodystrophy
- Ca2+ and Phosphate met controlled by PTH
- kidney cant respond to PTH to increase renal Ca2+ reabsorption
- persistent hyperparathyroidism.
- persistent hyperplasia of thyroid glands - may have to remove.
- hyperparathyroidism
Treat CKD two areas?
- conservative eg diet and drugs, treat symptoms
* renal replacement therapy
Renal replacement therapy CKD
- dialysis
* transplantation
Drug treatment with HYP & CKD
- diuretics
- BB
- alpha blockers
Diuretic CKD & HYP
- only LOOP eg Furosemide
- occasionally used for HYP mainly for oedema.
- thiazides ineffective at CrCl<25ml/min
- K sparing increases risk of hyperkalaemia
Diuretic thiazide
except metolozone, ineffective at CrCl<25ml/min
BB CKD & HYP
- cardioselective eg metoprolol, atenolol, bisoprolol
- Metoprolol cleared through liver
- start low dose, titrate up
Why metaprolol for HYP & CKD
- cardioselective
* cleared via liver
CCB HYP & CKD
• can produce oedema
especially Nifedipine
• confusion with symptoms of fluid overload
ACEis/ARB
- can decline renal fn
- fine is ESFR but increases risk of SE
- C/I: renal artery stenosis
Renal artery stenosis
blood flow to kidney relied upon Angiotensin 2 vasoconstriction
alpha-blokers
eg. doxazosin
• cleared through liver
vasodilators CKD & HYP
- eg hydralazine, minoxidil
- reserved when HYP not controlled by others
- SE: fluid retention so use w diuretic, reflex tachycardia
BP targets
<140/90
& DM: <130/80
Oedema CKD
- pulmonary
- diuretic
- LOOP in pre-dialysis stage
- Furosemide up to 2g OD (500mg tablet)
- Fluid and Na2+ restriction
- stop when dialysis starts
Hyperkalaemia CKD
- > 7mmol/l imperative due to risk of cardiac arrest.
* emergency treatments calcium gluconate, insulin + glucose, calcium resonium
Emergency treatment for hyperkalaemia & doses
- Calcium gluconate [10ml 10% IV over 5-10min]
- Insulin (20IU soluble) + Glucose (50ml 50% IV)
- Calcium resonium [15-30g powder oral/enema] with Lactulose 10ml/ 15g dose
Why Insulin & Glucose in hyperkalaemia treatment - pharmacology
- Insulin stimulates intracellular K+ uptake
* Glucose prevent hypoglycaemia
Why calcium resonium in hyperkalaemia treatment - pharmacology
- Ion exchange resin binds to K+ in GIT & releases Ca2+ in exchange
- always give with lactulose 10ml for each 15g dose as very constipating
Acidosis why & treatment
- kidney cant excrete H+ ions
- sodium bicarbonate 500-600mg TDS tab or powder
- only problem in pre-dialysis
Hyperphosphataemia why & treatment
- kidney cant excrete phosphate
* Phosphate binders eg Aluminium hydroxide, calcium carbonate, calcium acetate, sevelamer
Phosphate binder eg
- Aluminium hydroxide
- Calcium carbonate
- Calcium acetate
- Sevelamer
Phosphate binder pharamcology
- bind with phosphate in food in gut
- take with or just before meal
- dose by meal size
Hypocalcaemia why & treatment
- kidney cant produce active vitD
- Calcitrol 250ng OD- fully active
- Alfacalcidol 500ng-1mcg OD- partial active
Anaemia why & treatment
- kidney cant produce EPO, erythropoetin
- Recombinant human erythropoetins injections IV/SC
- Iron therapy
- avoid blood transfusions
Iron therapy in anaemia CKD. eg
- Iron sucrose [Venofer]
* Ferric cerboxymaltose [Ferinject]
Iron sucrose brand
Venofer
Ferric carboxymaltose brand
Ferinject
Venofer
Iron sucrose
Ferinject
Ferric carboxymaltose
Recombinant human erythropoetin inject SE
HYP
pure red cell aplasia
Cramps & restless legs CKS
- cramps at night/on dialysis
* restless leg syndrome
Cramps treatment CKD
• Quinine sulphate 300mg
Restless leg syndrome treatment
• Clonazepam 0.5-1mg nocte
Vitamin supplements CKD
- eg Renavit
- dietary advice
- water soluble vit removed by dialysis
Hepatitis B vaccine
- CKD pt
- get booster every 5yr
- HD pt monitored annually for antibodies and re-immunised if needed
- 3 doses of 40mcg [double normal dose]
which vaccine do CKD pt need
Hepatitis B
• every 5 years, booster
• monitor HD pt yearly
Dialysis types
- Haemo
* peritoneal
principal of dialysis
- artificial kidney, mimics normal kidney.
* mimic ultrafiltration & reabsorption
Membranes in dialysis HD and peritoneal
- HD = artificial membrane
* peritoneal = pt own peritoneal membrane
Ultrafiltration in dialysis
- remove waste
* remove water
How waste removed in dialysis
- diffuse down conc grad across membrane
* waste solutes from blood (high conc) to dialysate fluid (low conc)
how water removed in HD
hydrostatically with negative pressure grad from pump in HD machine
how water removed in peritoneal dialysis
osmotically using dialysate fluids containing various glucose concentrations
How reabsorption in dialysis
dialysate fluid = desired substances at normal conc to prevent diffusion/ no conc gradient.
Haemodialysis what is done?
- atrial blood taken from body
- anticoagulated (heparin)
- passed through artificial kidney
- countercurrent dialysate fluid bathes fibres & maximises conc grad.
- return to vein & dialysate discarded
Artificial kidney in HD made from?
hollow fibres.
• semi permeable membrane
HD where?
• hospital or home
HD when?
2-3 times a week, 3-4 hours.
HD fluid restriction
should not put on >1.5Kg above dry weight
Gain vascular access in HD
- subclavian
* ateriovenous fistula
Ateriovenous fistula in HD
- artery joined to vein
- matures over 6 wks
- 2 enlarged blood vessels to allow needling
- dont cover tightly or injure
Sub-clavian
- tunnelled under skin to subclavian vein
* temporary risk of infection
Ateriovenous shunt in HD
• two silastic tubes w Teflon connector inserted into vein and artery
Why Peritoneal membrane?
peritoneal membrane lines all internal organs & has rich blood supply
Peritoneal dialysis how?
- 1.5/2L sterile dialysis fluid run into peritoneal cavity under gravity
- fluid in abdomen for set time period
- diffusion occurs
- fluid drained out under gravity & discarded
- new fluid drained in
- repeated QDS
Access PD
- indwelling silastic catheter
- tunnelled through abdominal wall & distal end sits in peritoneal cavity
- aseptic techniques required when changing bags
- Peritonitis risk
- other risks eg loss of protein.
Types of PD
- CAPD - continuous ambulatory PD
- APD - automated peritoneal dialysis
- IPD - intermittent peritoneal dialysis
CAPD
continuous ambulatory PD
APD
automated PD
IPD
intermittent PD
Diet in PD
- healthy [low fat, low salt, high fibre]
- low K
- low phosphate
- high protein in CAPD
Fluid restriction
HD: urine output + 500ml/day
PD: urine output + 750ml/day
HD drugs removal
PD drugs removal
- low % plasma protein bound
- low Vd
- low m. wt/ molecular weight
- increase water solubility
- increase renal clearance in normal RF
increase HD via dialysis
- duration
- blood flow
- type of membrane
- flow rate & composition of fluid
Increase PD via dialysis
- composition of dialysate
- pathology of peritoneum
- volume & exchange rate of dialysate in peritoneal cavity • osmotic concentration gradient
Pre renal nephrotoxicity
- diuretics
- g.i.losses [D&V, laxative abuse]
- NSAIDs
- ACEIs
Classification of nephrotoxicity
- Pre-renal
- Intra-renal
- Post-renal
Intra-renal what? eg?
hypersensitivity reactions & unpredictable
• Glomerular lesions
• Interstitial damage
Glomerular lesions
- passive trapping of immune complexes in glomerulus causing inflammatory response
- eg gold, penicillamine, phenytoin, penicillins
Interstitial damage
- inflammation of cells lying between nephrons
* eg penicillins, allopurinol, azathioprine
Directly toxic and more predictable in dialysis
- can occur with single dose
* eg aminoglycosides, cyclosporin, amphotericin
Post renal what? eg?
- urinary tract obstruction eg methotrexate
- causing crystalluria
- crystals block outflow of urine, leads to back pressure, leads to damage to kidneys
Nephrotoxic drugs in renal patients?
sometimes essential
• monitor renal fn and signs of toxicity constantly
• ESFR, fine to use.
pruritis
itchy skin due to hyperphosphataemia